Cargando…
Expression of circulating angiotensin‐converting enzyme 2 in children with asthma and the effects of inhaled corticosteroids
BACKGROUND: The global spread of coronavirus disease 2019 (COVID‐19) has resulted in a significant disease burden, yet asthma patients do not have the expected high morbidity and mortality rates in the pandemics of COVID‐19. OBJECTIVE: To find the difference of angiotensin‐converting enzyme 2 (ACE2)...
Autores principales: | Ma, Xiang, Liu, Lesen, Sun, Jing, Zhang, Yun, Liu, Yanqin, Liu, Miao, Wang, Bing, Chang, Yuna, Han, Yuling, Gai, Zhongtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373566/ https://www.ncbi.nlm.nih.gov/pubmed/37506151 http://dx.doi.org/10.1002/iid3.922 |
Ejemplares similares
-
Inhaled corticosteroids and angiotensin-converting enzyme-2 in COPD
por: Lipworth, Brian, et al.
Publicado: (2021) -
Protective effect of inhaled corticosteroid on children with asthma with Mycoplasma pneumoniae pneumonia
por: Wei, Bing, et al.
Publicado: (2022) -
Effect of diagnosis delay on pulmonary function in children with asthma
por: Wei, Xiaoling, et al.
Publicado: (2022) -
Circulating angiotensin converting enzyme 2 and COVID-19
por: Leowattana, Wattana, et al.
Publicado: (2022) -
Epidemiological characteristics of common respiratory infectious diseases in children before and during the COVID-19 epidemic
por: Wang, Bing, et al.
Publicado: (2023)